Financial
FY2025 revenue $67.53bn (+7.6%); pre-tax margin 15.3%; net income $10.59bn.
Cash $14.50bn; debt $61.30bn.
HQ United States · North America
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
FY2025 revenue $67.53bn (+7.6%); pre-tax margin 15.3%; net income $10.59bn.
Cash $14.50bn; debt $61.30bn.
Source: official results release · Year ended 2025-12-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2025 | US$67.5bn | +7.6% | US$10.3bn | US$10.6bn | IBM |
Products not yet catalogued.
FY2025 revenue $67.53bn (+7.6%); pre-tax margin 15.3%; net income $10.59bn.
Cash $14.50bn; debt $61.30bn.
Jun 2026: a False Claims Act lawsuit by a former IBM threat-intelligence executive was unsealed, alleging IBM concealed foreign hacks of systems used by US government customers; the DOJ declined to intervene and IBM said it is confident it complied with the law.
Jun 2026: an unsealed whistleblower lawsuit alleges IBM failed to disclose repeated breaches by foreign state-backed hackers (including APT10, 2013-2016) to US government customers; IBM says it complied with the law. No regulator action found. NHS DSPT status not yet checked.
IT services and software supplier; no regulatory or clinical safety actions found in the last 24 months.
Feb 2025: NHS England increased the value of IBM's NHS App contract from £52.4m to £78.6m to fund new features; the core contract was due to expire in Jun 2026. Oct 2025: the DWP hired IBM to support AI projects.
No competitors linked yet.